Status:

COMPLETED

Low-Residue Diet in Treating Diarrhea in Patients Receiving Pelvic Radiation Therapy.

Lead Sponsor:

Case Comprehensive Cancer Center

Conditions:

Cervical Cancer

Diarrhea

Eligibility:

All Genders

20-80 years

Phase:

NA

Brief Summary

RATIONALE: Eating a diet low in residue (fiber, fat, and certain milk or vegetable products) may help prevent or reduce diarrhea caused by pelvic radiation therapy. PURPOSE: This randomized clinical ...

Detailed Description

OBJECTIVES: * Compare the nutritional status, Common Toxicity Criteria (CTC) score, and fecal incontinence quality of life (FI-QOL) in patients with uterine, cervical, or prostate cancer who are unde...

Eligibility Criteria

Inclusion

  • DISEASE CHARACTERISTICS:
  • Diagnosis of uterine, cervical, or prostate cancer
  • Current patient at the Ireland/Case Comprehensive Cancer Center
  • Planning pelvic radiation therapy within the next 4 months
  • PATIENT CHARACTERISTICS:
  • Performance status
  • Not specified
  • Life expectancy
  • Not specified
  • Hematopoietic
  • Not specified
  • Hepatic
  • Not specified
  • Renal
  • Not specified
  • Gastrointestinal
  • No enteric support
  • No inflammatory bowel disease
  • Other
  • No other concurrent illness or medical condition that would preclude study compliance
  • No history of allergies or dietary intolerances (e.g., lactose intolerance) that would preclude study treatment or interfere with study results
  • PRIOR CONCURRENT THERAPY:
  • Chemotherapy
  • No concurrent chemotherapy
  • Endocrine therapy
  • Concurrent hormonal therapy allowed (e.g., testosterone suppression)
  • Radiotherapy
  • See Disease Characteristics
  • Surgery
  • No prior colectomy
  • Other
  • No concurrent glutamine, psyllium, or other fiber supplements (e.g., Benefiber\^® or Metamucil\^®)

Exclusion

    Key Trial Info

    Start Date :

    May 1 2005

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    June 1 2006

    Estimated Enrollment :

    11 Patients enrolled

    Trial Details

    Trial ID

    NCT00258401

    Start Date

    May 1 2005

    End Date

    June 1 2006

    Last Update

    July 27 2020

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center

    Cleveland, Ohio, United States, 44106-5065